Skip to main content
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. — Investor Relations & Filings

Ticker · PCRX ISIN · US6951271005 LEI · 549300P56LERYBDHCF69 US Manufacturing
Open in API
Filings indexed 1,217 across all filing types
Latest filing 2021-05-04 Earnings Release
Country US United States of America
Listing US PCRX

About Pacira BioSciences, Inc.

https://www.pacira.com/

Pacira BioSciences, Inc. is a pharmaceutical company that develops, commercializes, and manufactures non-opioid pain management and regenerative health solutions. The company's mission is to provide alternatives to opioids by delivering innovative, precise, and targeted therapies. Its products and research pipeline address a diverse range of needs, including postsurgical, chronic, and musculoskeletal pain. Pacira is also focused on developing advanced solutions, including gene therapy, to address unmet needs in pain management.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions "Item 2.02. Results of Operations and Financial Condition" and states that the company issued a press release announcing its financial results for the first quarter ended March 31, 2021. It also references an attached earnings press release as Exhibit 99.1. The document itself is not the full earnings release but a filing to announce the earnings release. The document length is 3373 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, initial announcements of quarterly financial results (key highlights only) correspond to the Earnings Release (ER) category. Therefore, this document should be classified as an Earnings Release (ER).
2021-05-04 English
DEF 14A
Proxy Solicitation & Information Statement
2021-04-22 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a definitive proxy statement or additional materials related to a shareholder meeting. It includes details about voting items such as election of directors, ratification of auditors, approval of executive compensation, and stock incentive plans. The presence of proxy voting instructions and meeting details confirms this is proxy solicitation material. The document is not the actual annual report or financial statements but materials sent to shareholders to provide information and request votes for the meeting. Therefore, it fits the Proxy Solicitation & Information Statement category (PSI). The document length is 4513 characters, which is consistent with a proxy statement or related materials rather than a full annual report or other filings.
2021-04-22 English
FORM 4 SUBMISSION
Director's Dealing
2021-04-16 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions "Item 2.02. Results of Operations and Financial Condition" and refers to a press release announcing preliminary unaudited revenue for the quarter ended March 31, 2021. The document includes a press release as an exhibit but does not contain detailed financial statements or comprehensive analysis itself. The length is 3385 characters, which is relatively short and consistent with a current report rather than a full quarterly or annual report. The document is primarily an announcement of preliminary financial results, which aligns with the definition of an Earnings Release (ER). Therefore, the appropriate classification is Earnings Release (ER).
2021-04-07 English
FORM 4 SUBMISSION
Director's Dealing
2021-04-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.